Nosium AB (NGM:NOSIUM B) 5-Year EBITDA Growth Rate: 17.60% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:NOSIUM B Nosium AB NGM:NOSIUM B
40 GF Score
Price kr2.30
GF Value kr1.40
! 6 Warning Signs
View Full Analysis

What is Nosium AB 5-Year EBITDA Growth Rate?

Nosium AB NGM:NOSIUM B +5.99% 40 5-Year EBITDA Growth Rate is 17.60% as of Mar. 2026. GuruFocus rates NGM:NOSIUM B with a GF Score™ of 40/100 and a GF Value™ of kr1.40. The stock has 6 warning signs investors should review.

Nosium AB's EBITDA per Share for the three months ended in Mar. 2026 was kr-0.23.

During the past 3 years, the average EBITDA Per Share Growth Rate was 27.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 17.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Nosium AB was 27.00% per year. The lowest was -36.80% per year. And the median was 1.00% per year.


Nosium AB  (NGM:NOSIUM B) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Nosium AB 5-Year EBITDA Growth Rate Related Terms


NGM:NOSIUM B vs BLK, BX, KKR: 5-Year EBITDA Growth Rate Comparison

For the Asset Management subindustry, Nosium AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nosium AB 5-Year EBITDA Growth Rate vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Nosium AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Nosium AB's 5-Year EBITDA Growth Rate falls into.


NGM:NOSIUM B
40GF Score
Nosium AB NGM:NOSIUM B
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nosium AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 17.60% mean?
Nosium AB (NGM:NOSIUM B) has a 5-Year EBITDA Growth Rate of 17.60% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Nosium AB and its competitors.
Is Nosium AB's 5-Year EBITDA Growth Rate too high?
Nosium AB's current 5-Year EBITDA Growth Rate is 17.60%. Overall, Nosium AB has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Nosium AB's 5-Year EBITDA Growth Rate compare to BLK and BX?
Nosium AB's 5-Year EBITDA Growth Rate of 17.60% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for an Asset Management company?
A good 5-Year EBITDA Growth Rate depends on the Asset Management industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Nosium AB and its competitors. Nosium AB's current 5-Year EBITDA Growth Rate is 17.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nosium AB stock overvalued right now?
Nosium AB (NGM:NOSIUM B) has a current 5-Year EBITDA Growth Rate of 17.60%. The stock's GF Value™ is kr1.40, compared to a current price of kr2.30 — trading 64.3% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 17.60%. Nosium AB's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Nosium AB (NGM:NOSIUM B), the current 5-Year EBITDA Growth Rate is 17.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nosium AB (NGM:NOSIUM B) Overvalued in 2026?

Based on GuruFocus' analysis, Nosium AB stock appears to be overvalued. The current stock price of kr2.30 is trading 64.3% above its estimated GF Value™ of kr1.40.

Key valuation signals for NGM:NOSIUM B:

  • 5-Year EBITDA Growth Rate: 17.60%
  • GF Value™: kr1.40 vs. price of kr2.30 (64.3% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the NGM:NOSIUM B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nosium AB Business Description

Address Artillerigatan 6, Stockholm, SWE, 11451
Nosium AB invests in companies with operations online, organic and sustainable. It owns, manages, and acquires shares in companies where it can increase growth and market value by implementing new digital strategies. Its investments are found in innovative tech platforms and product brands that target a health and sustainability-conscious target group.
40GF Score

Get the complete analysis for NGM:NOSIUM B

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.30
Price
kr1.40
GF Value